AMS Mayer, VA Mayer, M Swanson-Mungerson… - Marine Drugs, 2024 - mdpi.com
The current 2019–2021 marine pharmacology literature review provides a continuation of previous reviews covering the period 1998 to 2018. Preclinical marine pharmacology …
Phytoplankton, the ecological group of microalgae adapted to live in apparent suspension in water masses, is much more than an ecosystem's engineer. In this opinion paper, we use …
Cyanobacteria and microalgae contain various phytochemicals, including bioactive components in the form of secondary metabolites, namely flavonoids, phenolic acids …
T Nawaz, L Gu, S Fahad, S Saud, Z Jiang… - Food and Energy …, 2023 - Wiley Online Library
Marine cyanobacterial bioactives, due to their diverse chemistry and promising pharmacological properties, hold significant potential as therapeutic agents. Here, we …
L Chen, J Huang, X Li, M Huang, S Zeng… - … in Bioengineering and …, 2022 - frontiersin.org
Photodynamic therapy (PDT) is an advanced therapeutic strategy with light-triggered, minimally invasive, high spatiotemporal selective and low systemic toxicity properties, which …
The marine environment is highly diverse, each living creature fighting to establish and proliferate. Among marine organisms, cyanobacteria are astounding secondary metabolite …
J Greve, A Mogk, U Kazmaier - Marine Drugs, 2022 - mdpi.com
Ilamycins/rufomycins are marine cycloheptapeptides containing unusual amino acids. Produced by Streptomyces sp., these compounds show potent activity against a range of …
Microalgae are microscopic organisms that have a broad range of applications, from wastewater treatment, CO2 mitigation to therapeutic proteins, and pharmaceuticals …
Nanotechnology has the potential to revolutionize various fields of research and development. Multiple nanoparticles employed in a nanotechnology process are the magic …